Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
India's Sensex and Nifty Turn Higher in Afternoon as Pharma Shares Gain
India's Sensex and Nifty 50 reversed morning losses Monday, climbing in afternoon trading alongside pharmaceutical stocks after four consecutive sessions of declines. The Sensex stood at 73,381.01 at 4:47 a.m. EDT (08:47 UTC), up 257.18 points, or…
Stock Market Today Live, October 26: Stocks to watch: Raymond, RailTel, KEC Intl, Honasa, BL Kashyap, Lupin, Orchid Pharma, Gland Pharma
Sensex Today, Nifty 50 | Stock Market Live Updates: Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 26th October 2026. Markets fell for a fourth consecutive session on Friday, weighed…
Stocks to watch October 26: Raymond, RailTel, KEC Intl, Honasa, BL Kashyap, Lupin, Orchid Pharma, Gland Pharma among 15 stocks to be in focus
The Board of Directors Raymond Ltd has approved a proposal to change the name of the company to Raymond Aerospace, Defence & Engineering Ltd. RailTel Corporation of India Ltd has received the Letter of Intent (LoI) from Munitions India Ltd for Rs…
Torrent Pharma eyes semaglutide launch in Brazil in 6-9 months
Torrent Pharmaceuticals plans to launch semaglutide in Brazil over the next six to nine months, as the drugmaker seeks to expand its presence in a market where revenues grew 38 per cent in the September quarter, Managing Director Aman Mehta said.
Avalyn Pharma Inc. (NASDAQ:AVLN) Stock Now Rated 'Moderate Buy' by Sell-Side Brokerages
Shares of Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) have earned a consensus recommendation of 'Moderate Buy' from the seven analysts that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the…
Brookstone Capital Management Buys 35,375 Shares of Royalty Pharma PLC $RPRX
Brookstone Capital Management bought a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 35,375 shares…
42,609 Royalty Pharma PLC $RPRX Shares Sold by Inspire Investing LLC
Inspire Investing LLC decreased its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 53.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor…
Ascendis Pharma A/S $ASND Shares Newly Bought by Inspire Investing LLC
Inspire Investing LLC acquired a new stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 10,428 shares of the…
Forget Biotech's Binary Bets: This Dividend Stock Collects Royalties on Blockbusters Instead
Biotech companies are high-risk, high-reward investments. Usually, a biotech has just one drug in development, and if it gets that drug to market, you win. If the drug doesn't work out, you lose. You don't have to make binary bets like that if you…
€795k Private Douglas home is in prime location and has big potential
Fresh to the market this Moneygurney home wasn't long attracting attention. As soon as five-bed detached Eton Brae ‘went live' there were calls requesting viewings. Agent Michael Downey of ERA Downey McCarthy wasn't surprised at the level of…
Stock Markets Today: Sensex, Nifty Decline as Crude Prices, Geopolitical Risks Weigh on Sentiments
Indian stock markets, including the Sensex and Nifty, are experiencing a downturn driven by a combination of elevated crude oil prices, escalating geopolitical tensions, and investor apprehension ahead of the crucial US Federal Reserve policy…
Sensex surges over 480 points
The Indian equity markets ended higher on Monday with Sensex surging over 480 points and Nifty settling above 22,750 level. This rally was supported by selective buying in metals, pharmaceuticals and healthcare, rather than a decisive improvement…
Nifty Prediction Today - October 26, 2026: Nifty futures: Bulls face a test
Nifty 50 opened today's session with a gap-down at 22,524 versus last week's close of 22,600. It is now hovering around 22,600. The advance/decline ratio stands at 25/25. BSE (up 4 per cent) and Dr. Reddy's Laboratories (up 3.4 per cent) are the…
After a long, strange trip, this CEO is close to taking a psilocybin pill to market
In 2022, Kabir Nath had a cushy executive job at a pharmaceutical firm that developed anti-psychotic medication. Then he got a call from a scrappy upstart with a patent on a synthetic version of psilocybin — the active ingredient in magic…
At ESMO, AstraZeneca's cancer pursuits get a showcase
MADRID — For AstraZeneca, a major oncology conference here this weekend has been a sign of how the company's cancer work is steamrolling ahead, with highlights from a mix of old standbys and new molecules that could expand its armament of…
Receive a Daily briefing on Pharma Industry News
Get Started